NCT03744572 is a clinical trial in Peripheral Artery Disease (PAD), sponsored by Michael Lichtenberg, MD.

Who is sponsoring NCT03744572?

NCT03744572 is sponsored by Michael Lichtenberg, MD.

What condition does NCT03744572 study?

NCT03744572 studies Peripheral Artery Disease (PAD).

Is NCT03744572 still recruiting?

NCT03744572 is currently completed. Last updated 26 January 2023.

Last reviewed 2023-01-26 · How we verify

NCT03744572

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Prestige Pilot - Phoenix Atherectomy and Stellarex DCB Clinical Investigation in Infrapopliteal Interventions

Completed Last updated 26 January 2023

What this trial tests

trial in Peripheral Artery Disease (PAD) in 56 participants. Completed in 1 June 2022.

Timeline

17 October 2018

Primary endpoint
22 December 2020

1 June 2022

Quick facts

Lead sponsor	Michael Lichtenberg, MD
Status	Completed
Study type	OBSERVATIONAL
Enrollment	56
Start date	17 October 2018
Primary completion	22 December 2020
Estimated completion	1 June 2022
Sites	5 locations across Germany

Conditions studied

Peripheral Artery Disease (PAD) — all drugs for Peripheral Artery Disease (PAD) →

Sponsor

Michael Lichtenberg, MD

Who can join

18 and older, any sex, with Peripheral Artery Disease (PAD). Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This pilot study is to investigate if a lesion preparation strategy with Phoenix atherectomy before DCB (drug coated balloon) usage in patients with PAD (peripheral artery disease) Rutherford Stage 4-5 and mild/moderate/severe calcium can improve outcomes including patency and limb salvage and evaluate safety and performance of the combination therapy

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Peripheral Artery Disease (PAD)

Currently open trials in the same condition.

NCT07226193 — Detecting Peripheral Artery Disease With the Pulse · NA · recruiting
NCT07313410 — Using Near-Infrared Light to Better Understand Peripheral Artery Disease · recruiting
NCT07169045 — Validity and Reliability of the 6-minute Stepper Test in Patients With Peripheral Artery Disease · recruiting
NCT06687590 — Serranator POINT FORCE Registry · recruiting
NCT06605209 — Safety and Effectiveness of the Peripheral Balloon-Expandable Covered Stent System for Iliac Artery Stenosis/Occlusion. · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03744572 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Michael Lichtenberg, MD
Last refreshed: 26 January 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03744572.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing